Literature DB >> 11430394

A prospective comparison of four antihypertensive agents in daily clinical practice.

C Campo1, J Segura, M L Fernández, L Guerrero, H Christiansen, L M Ruilope.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11430394      PMCID： PMC8112381          DOI： 10.1111/j.1524-6175.2001.00448.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  17 in total

1.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors:  L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

2.  Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines?

Authors:  E Abergel; G Chatellier; C Battaglia; J Menard
Journal:  J Hypertens       Date:  1999-06       Impact factor: 4.844

3.  The rational clinical examination. Is this patient taking the treatment as prescribed?

Authors:  B J Stephenson; B H Rowe; R B Haynes; W M Macharia; G Leon
Journal:  JAMA       Date:  1993-06-02       Impact factor: 56.272

4.  Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

Authors:  S E Kjeldsen; B Dahlöf; R B Devereux; S Julius; U de Faire; F Fyhrquist; H Ibsen; K Kristianson; O Lederballe-Pedersen; L H Lindholm; M S Nieminen; P Omvik; S Oparil; H Wedel
Journal:  Am J Hypertens       Date:  2000-08       Impact factor: 2.689

5.  Influence of diabetes and type of hypertension on response to antihypertensive treatment.

Authors:  M J Brown; A Castaigne; P W de Leeuw; G Mancia; C R Palmer; T Rosenthal; L M Ruilope
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

6.  Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions.

Authors:  M L Bots; A W Hoes; A Hofman; J C Witteman; D E Grobbee
Journal:  J Intern Med       Date:  1999-03       Impact factor: 8.989

Review 7.  Microalbuminuria in essential hypertension.

Authors:  J L Rodicio; C Campo; L M Ruilope
Journal:  Kidney Int Suppl       Date:  1998-12       Impact factor: 10.545

8.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Therapeutic response may be predicted by some clinical parameters in essential hypertensive patients.

Authors:  A De la Sierra; A Coca; J Sobrino; M M Lluch; M Sánchez; A Urbano-Márquez
Journal:  J Hum Hypertens       Date:  1991-10       Impact factor: 3.012
View more
  1 in total

Review 1.  Factors influencing the systolic blood pressure response to drug therapy.

Authors:  Carlos Campo; Julián Segura; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.